Content about Endocrine system

September 19, 2010

An injected insulin made by French drug maker Sanofi-Aventis provided further reduction of blood sugar...

PARIS An injected insulin made by French drug maker Sanofi-Aventis provided further reduction of blood sugar in patients with Type 2 diabetes when added to oral diabetes drugs, according to a study presented at a medical conference in Sweden.

September 14, 2010

Oramed Pharmaceuticals has seen promising results from a clinical trial of an oral insulin for...

JERUSALEM Oramed Pharmaceuticals has seen promising results from a clinical trial of an oral insulin for diabetes, the Israeli drug maker said.

 

The company said its exploratory clinical trial of the oral insulin capsule ORMD-0801 was successful. The company is developing the capsule as a treatment for patients with uncontrolled Type 1 diabetes. The company also is developing the oral insulin as a treatment for Type 2 diabetes.

 

 

September 12, 2010

The Food and Drug Administration has approved a new dosage of an AstraZeneca drug for...

WILMINGTON, Del. The Food and Drug Administration has approved a new dosage of an AstraZeneca drug for treating breast cancer, AstraZeneca said Friday.

 

The Anglo-Swedish drug maker announced the approval of the 500-mg dose of the injected drug Faslodex (fulvestrant) for treating breast cancer that has spread to other parts of the body –– also known as metastasis –– in postmenopausal women after they have received anti-estrogen therapy. The new dosage replaces the previous 250-mg dose of the drug.

 

September 9, 2010

A leading provider of award-winning mobile 3G technology and applications recently launched a mobile app...

LOS ANGELES A leading provider of award-winning mobile 3G technology and applications recently launched a mobile app for diabetics.

August 31, 2010

A specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes...

August 29, 2010

Novo Nordisk has launched a mobile dosing app for healthcare professionals that prescribe the drug...

PRINCETON, N.J. Novo Nordisk has launched a mobile dosing app for healthcare professionals that prescribe the drug maker's insulin products.

NovoDose, which is available for download on iTunes, allows physicians to select the type of insulin they want to research and review suggested guidelines for dosing, titration and even blood glucose goals for their patients. The app also provides important safety information on the products, and only those who self-identify as healthcare professionals can download the app.

August 26, 2010

The FDA approved Sandoz Omnitrope (somatropin [rDNA origin]) as a treatment for idiopathic short stature,...

August 26, 2010

Those with Type 2 diabetes may be at greater risk of developing the brain plaques...

NEW YORK Those with Type 2 diabetes may be at greater risk of developing the brain plaques associated with Alzheimer’s disease, new research suggested.

According to a Japanese study, which appeared in the Aug. 25 online issue of the journal Neurology, those individuals with the highest levels of insulin resistance had nearly six times the odds of developing plaque deposits between the nerves in the brain, after adjusting for other risk factors, compared with those with the lowest levels of fasting insulin.

August 15, 2010

The Juvenile Diabetes Research Foundation has expanded its artifical pancreas program with an initiative that...

August 8, 2010

A company that develops healthcare and information management products has applied for a patent for...

DELRAY BEACH, Fla. A company that develops healthcare and information management products has applied for a patent for an insulin-pen tracking and recording device.

 

July 11, 2010

The Juvenile Diabetes Research Foundation has given two research grants to drug maker Biodel to...

July 11, 2010

An enzyme produced by the body may make it easier to detect diabetes, according to...

June 30, 2010

Endo Pharmaceuticals has resubmitted its application to the Food and Drug Administration for a testosterone...

June 30, 2010

Nipro has named a new president for its Nipro Diagnostics division, the company announced Thursday....

June 24, 2010

An inhaled insulin made by MannKind for patients with Type 2 diabetes provides glycemic control...

June 24, 2010

French drug maker Sanofi-Aventis has made a deal with U.S. drug maker Metabolex to license...

June 21, 2010

The nation's largest retailer has teamed up with a drug company to provide an affordable...

INDIANAPOLIS The nation's largest retailer has teamed up with a drug company to provide an affordable insulin option for people with diabetes.

Lilly's Humulin will be offered by mid-September to Walmart pharmacy patients under the dual-branded name Humulin ReliOn, including 10 mL vials of Humulin R U-100, Humulin N and Humulin 70/30 formulations.

June 13, 2010

Home Diagnostics and Nipro Diabetes Systems earlier this week announced that the two companies will...

June 13, 2010

Teva Pharmaceutical Industries has invested $11.9 million in Andromeda Biotech, a company that develops diabetes...

June 9, 2010

An investigational insulin made by MannKind works at least as well in patients with Type...

June 8, 2010

Unigene Labs has appointed a new leader, the company said Wednesday....

June 6, 2010

Becton, Dickinson and Co. has launched what the company calls the world's smallest insulin pen...

FRANKLIN LAKES, N.J. Becton, Dickinson and Co. has launched what the company calls the world's smallest insulin pen needle.

The BD Ultra-Fine Nano provides glucose control of typical longer insulin pen needles but with less pain upon injection, BD said.

 

May 31, 2010

Amylin has named a new SVP research and development and SVP and chief medical officer,...

May 23, 2010

The Food and Drug Administration approved blood-glucose test strips from Abbott....

May 17, 2010

A branded drug made by Teva Pharmaceutical Industries reduced the frequency of nighttime awakenings due...